In vitro systems toxicology-based assessment of the potential modified risk tobacco product CHTP 1.2 for vascular inflammation- and cytotoxicity-associated mechanisms promoting adhesion of monocytic cells to human coronary arterial endothelial cells.

导出 LinkOut

翻译打印收藏纠错

第一作者： Carine,Poussin

第一单位： PMI R&D, Philip Morris Products S.A., Part of Philip Morris International Group of Companies, Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland. Electronic address: Carine.Poussin@pmi.com.

作者： Carine,Poussin ^[1] ; Alexandra,Laurent ^[2] ; Athanasios,Kondylis ^[2] ; Diego,Marescotti ^[2] ; Marco,van der Toorn ^[2] ; Emmanuel,Guedj ^[2] ; Didier,Goedertier ^[2] ; Stefano,Acali ^[2] ; Claudius,Pak ^[2] ; Rémi,Dulize ^[2] ; Karine,Baumer ^[2] ; Dariusz,Peric ^[2] ; Elodie,Maluenda ^[2] ; David,Bornand ^[2] ; Ignacio Gonzalez,Suarez ^[2] ; Walter K,Schlage ^[3] ; Nikolai V,Ivanov ^[2] ; Manuel C,Peitsch ^[2] ; Julia,Hoeng ^[2]

作者单位： PMI R&D, Philip Morris Products S.A., Part of Philip Morris International Group of Companies, Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland. Electronic address: Carine.Poussin@pmi.com. ^[1] PMI R&D, Philip Morris Products S.A., Part of Philip Morris International Group of Companies, Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland. ^[2] Biology Consultant, Max-Baermann-Str. 21, 51429 Bergisch Gladbach, Germany. ^[3]

关键词 Adhesion Atherosclerosis Cigarette Endothelial cell Modified risk tobacco product Monocyte